complex in vitro models to study oral application and exposure · 2014-01-03 · complex in vitro...

29
Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 [email protected] Helmholtz Institute for Pharmaceutical Research Saarland Department of Drug Delivery (DDEL)

Upload: others

Post on 02-Aug-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Complex in vitro models to study oral application and exposure

Berlin, 8. Mai [email protected] Institute for Pharmaceutical Research SaarlandDepartment of Drug Delivery (DDEL)

Page 2: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Inflammatory bowel disease

A group chronic or recurrent inflammatory conditions of the colon and small intestine (Crohn’s Disease and Ulcerative Colitis)

Symptoms: diarrhea, weight loss, pain

Treatment: induction and maintenance ofremission using immunosuppresents, glucocorticoids, monoclonal antibodies(anti TNF-α)

Page 2 |

Page 3: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

State of the art: animal models in drug/formulation development for IBD treatment

Rodent colitis models-Transgenic- Chemically induced, e.g. TNBS, DSS

Arita M et al. PNAS 2005;102:7671-7676

Symptoms:Diarrhea, rectal bleeding, weight loss, pain, colon perforation, sepsis, death

Evaluation of treatment: scoring system, histological stainings, weight and length of colon

Issues: unethical, differences in species and pathogenesis

Page 3 |

Page 4: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

The work horse: the Caco-2 model

Caco-2 monolayer Intestinal mucosa

Page 4 |

Page 5: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Adding complexity: immune cells

Page 5 |

Page 6: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

In vitro model of the inflamed intestinal mucosa

Page 6 |

Co-culture of Caco-2 intestinal epithelial cells with blood derived dendritriccells and macrophages

Stimulation of inflammation by addition of lipopolysaccharides orpro-inflammatory cytokines (interleukin-1β) to the cell culture medium

Reflects the relevant pathophysiological changes occuring in vivo

Page 7: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

In vitro model of the inflamed intestinal mucosa

Page 7 |

Collagen layer

Filter membrane

Page 8: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

In vitro model of the inflamed intestinal mucosa:release of pro-inflammatory marker IL-8

Page 8 |

Leonard et al, Mol Pharm: 7, 2103 – 2119, 2010

Page 9: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Tight junction protein ZO-1control

inflamed

IL-1ß stimulation

In vitro model of the inflamed intestinal mucosa:changes in barrier properties

Page 9 |

Leonard et al, Mol Pharm: 7, 2103 – 2119, 2010

Page 10: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Pathophysiological changes in the inflamed mucosa:Threat or potential?

Healthy mucosal barrier Inflamed mucosal barrier

Macrophage

Intestinal epithelial cell

Tight junctions

MicroparticleNanoparticle

Page 10 |

Collnot et al, J Control Release 2012, in press

Page 11: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Budesonide formulations for the treatment of IBD

Budesonide PLGA nanoparticles Liposomal budesonide

size ~220 nm, PDI: 0.08 size ~ 200 nm, PDI: 0.05 encapsulation rate: 67 µg/mg encapsulation rate: 4.2 mg/mlencapsulation efficiency: 46% encapsualtion efficiency: 4.2%

Diluted or suspended in Caco-2 medium to a concentration of 100 µg/ml

Page 11 |

Page 12: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Testing of anti-inflammatory formulations in the inflamed 3D model

Page 12 |

Leonard et al, ALTEX, accepted

Page 13: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Testing of anti-inflammatory formulations in the inflamed 3D model

Budesonide PLGA nanoparticles

Liposomal budesonide

Leonard et al, ALTEX, acceptedPage 13 |

Page 14: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Toxicity testing of engineered nanoparticles: InLiveTox

Page 14 |

Page 15: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Toxicity testing of engineered nanoparticles: the candidates

NP Nominal Water Completemedium

Ag, PVP capped, NM300

< 20 nm 150 nm 120 nm

TiO2NM 101

7-10 nm >1000 nm 800 nm

Au,Phosphine capped

15 nm 20 nm 51 nm

Au, Phosphine capped

80 nm 88 nm 116 nm

Polystyrene 55 nm 60 nm 55 nm

Polystyrene 211 nm 230 nm 550 nm

Page 15 |

Page 16: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Toxicity testing in the co-culture model: LDH release

Ag NP concentration [µg/cm2]

1 10 100 1000

Cyt

otox

icty

[%]

-20

0

20

40

60

80

100

120

140

Caco-2 monoculture EC50 = 82 µ/cm²not inflamed triple culture EC50 = 364 µg/cm²inflamed triple culture EC50 = 216 µg/cm²

Page 16 |

Page 17: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

What‘s the reason for the differences observed?

Relative cell numbers in the mature 3D culture:

~106 Caco-2 cells vs. 104 immune cells

LDH leakage and drop in metabolic activity is mainly associated with the Caco-2 cells

Reduced exposure of epithelial cells in the presence of immune cells due to preferential uptake by dendritic cells and macrophages?

Page 17 |

Page 18: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Toxicity testing in the co-culture model: IL-8 production

Ag NP concentration [µg/cm2]

1,25 2,5 5 9,7719,53

39,06578,125

156,25312,5 625

IL8

rele

ase

[pg/

ml]

0

200

400

600

800

1000

1200

1400

Baseline non-inflamedBaseline inflamed

Baseline Caco-2

Caco-2non-inflamed triple cultureinflamed triple culture

Page 18 |

Page 19: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Toxicity testing in the co-culture model

Filtrer membrane

Caco-2 cellsNanoparticles

Page 19 |

Page 20: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Toxicity testing in the co-culture model

Dendritic cells

Macrophages

Collagen layer

Filter membrane

Nanoparticles

Caco-2 cells

Protective function of the immune cells in the 3D culture:• preferential uptake of NM300 Ag NP• reduced exposure of epithelial cells• induction of immune answer in response to xenobiotic threats

Page 20 |

Page 21: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Toxicity testing of engineered nanoparticles: InLiveTox

Page 21 |

Page 22: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Dynamic cell culture and interconnected systems: InLiveTox

Page 22 |

Page 23: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

The next generation: The InLiveTox system-Interconnected culture and systemic uptake-

Page 23

ILT2: Caco-2ILT0: HUVEC

ILT0: C3A

Lower circuit, medium reservoirUpper circuit, medium reservoir

Bubble trap

Page 24: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

It‘s all about support: silica membranes

0,5 µm10 µm

Page 24 |

Page 25: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

It‘s all about support: silica membranes

Caco-2

Page 25 |

ZO-1

Page 26: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

It‘s all about support: improved transport properties

Page 26 |

1 µm CSEM

2 µm CSEM

3 µm CSEM

0,4 µm BD

1 µm BD

3 µm BD

0,4 µm Corning

3 µm Corning

Nan

opar

ticle

s am

ount

in b

asol

ater

al c

ompa

rtmen

t nor

mal

ized

with

initi

al a

mou

nt a

nd c

ompa

rtmen

t rat

io

0,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1 h 4 h 24 h

1µm 2µm 3µm 0.4µm 1µm 3µm 0.4µm 3µm

Silicon nitride BD membrane Corningmembrane membrane

Page 27: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

It‘s all about support: automated TEER measurements

Page 27 |

Page 28: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Summary

New tools for pharmakokinetic/toxikokinetic and mechanistic in vitro studies

3D co-culture model of the non-inflamed and inflamed intestinal mucosa

Modular two flow system with automated TEER measurements

Silica nitride based membranes with good cell growth properties and improved transport behaviour for macromolecules and nanoparticles

Page 28 |

Page 29: Complex in vitro models to study oral application and exposure · 2014-01-03 · Complex in vitro models to study oral application and exposure Berlin, 8. Mai 2012 eva-maria.collnot@helmholtz-hzi.de

Acknowledgements

• HIPS/Saarland UniversityFransisca LeonardJulia SusewindNadia UcciferriClaus-Michael Lehr

• Utrecht UniversityBart CrielaardTwan LammersGert Storm

• Centre Suisse d’Electronique et de MicrotechniqueSher AhmedMelanie FavreSilvia AngeloniMartha Liley

• University of Pisa, Department of engineeringTommaso SbranaArti Ahluwalia

Page 29 |

Thank you for your attention!